Achalasia, EsophagealAchalasiaIndocyanine Green (ICG)Indocyanine Green
Study summary
The aim this prospective observational study is to evaluate the role of Indocyanine Green Fluorescence (ICG) in patients with achalasia underwent to Heller-Dor laparoscopic. The main gol are:
* If with use of ICG iatrogenic mucosal leaks can be identified and, if necessary, improve the myotomy.
* Assess the need for postoperative radiographic control using esophagogastric radiography with gastrografin.
* Compare clinical characteristics, perioperative outcomes, and 12-month postoperative follow-up between the two populations.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* patients with achalasia of type I and II
* patients undergoing laparoscopic Heller-Dor
* patients older than 18 years
Exclusion Criteria:
* Patients \<18 years of age;
* Uncooperative patients and/or patients unable to provide informed consent
* ASA ≥4
* BMI ≥30
* Patients previously treated with other endoscopic/surgical procedures (botulinum toxin injections, dilation, POEM, myotomy)
* Patients with achalasia type III
* Patients with megaesophagus
* Allergy to dyes or contrast agents included in the protocol (e.g., indocyanine green, barium, gastrografin)
Primary outcome measure(s)
mucosal leak — Intraoperative Directly visualize intraoperatively the presence or absence of an esophageal mucosal lesion through the color change due to indocyanine green fluorescence.
Completeness of myotomy — intraoperative Intraoperatively visualize the presence or absence of residual muscle fibers after myotomy through the use of indocyanine green fluorescence.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
